Syenex
Syenex is a precision delivery platform company for genetic medicine. Its VivoCell platform uses engineered, targeted lentiviral vectors to help partners develop in vivo cell therapies across autoimmune disease and oncology, controlling both where a therapy goes and where it is expressed. Built from ready-to-use components, VivoCell delivery can be tailored in weeks, not years. Syenex accelerates partners speed to clinical impact through royalty-free licensing, expert support from prototype to IND, a growing CDMO and CRO partner network, and ongoing access to expanded platform innovation.
